Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (12015)	8/18/2003 3:30:17 PM
From: afrayem onigwecher	Read Replies (1) \| Respond to of 19428

:04pm 06/03/02 Immtech soars as co. sees no reason for recent slide (IMMT) By Tomi Kilgore Shares of Immtech International (IMMT) are soaring $1.51, or 49 percent, to $4.61 after the company said there were no developments that it was aware of that would account for the recent slide. In the previous two sessions, the shares had fallen 46 percent. The company assured that its development efforts of its drugs "are on track" and that results have met or exceeded expectations. The company's treatment for Trypanosomiasis (African sleeping sickness) and PCP (a fungal infection in the lungs) are currently progressing with Phase II trials.